TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study.

David M O'Malley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.